COVID-19 and HIPAA
During the COVID-19 national emergency, which also constitutes a nationwide public health emergency, the HHS Office for Civil Rights (OCR) has provided guidance that helps explain how the HIPAA Privacy Rule allows patient information to be shared in the outbreak of infectious disease and to assist patients in receiving the care they need. The district will follow federal guidelines relating to HIPAA and Protected Health Information (PHI).
Consent/Insurance Release: I, the undersigned, understand and grant permission to One Love Laboratory to bill my insurance for laboratory services provided. I understand that the services provided may not be covered by my insurance. I further understand that I am not responsible for co-pays, deductibles, and any amount not covered by my insurer. By signing below, I acknowledge that payment may be made on my behalf to One Love Laboratory. I hereby authorize the ordering physician and/or clinic to disclose any personal or medical information that may be needed to process claims related to services rendered by One Love Laboratory and its affiliates. I understand that my records may be protected under 42 CFR Part 2, under which I may revoke my consent at any time except to the extent that action has been taken in reliance on it, and that in any event, this consent expires six (6) months after the date of program discharge. I consent for One Love Laboratory, Greensboro Public Health Department, and the North Carolina Health Department to receive a copy of my results.